Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001683168-24-005073
Filing Date
2024-07-26
Accepted
2024-07-26 08:30:04
Documents
1

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS cns_424b5.htm 424B5 376575
  Complete submission text file 0001683168-24-005073.txt   377613
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

EIN.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-279285 | Film No.: 241143627
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)